Therapeutic management of chronic suppurative otitis media with otic drops.
The use of potentially ototoxic topical drugs is controversial. Few experimental reports of audiometric data from human subjects exist. The purpose of this study is to determine if a significant difference between bone conduction hearing sensitivity before and after otic drop treatment for children with chronic suppurative otitis media and patent ventilation tubes exists. A statistical analysis of sensorineural threshold status after treatment of chronic suppurative otitis media with otic drops is presented.
Merifield
D O
DO
Tulsa Otolaryngology, OK 74104.
Parker
N J
NJ
Nicholson
N C
NC
D000617:Aminoglycosides; D000704:Analysis of Variance; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D001299:Audiometry; D001309:Auditory Threshold; D001844:Bone Conduction; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D004338:Drug Combinations; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced* / Q000175:diagnosis / Q000209:etiology; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage* / Q000009:adverse effects*; D007223:Infant; D007322:Instillation, Drug; D008297:Male; D008876:Middle Ear Ventilation; D010035:Otitis Media, Suppurative / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D011113:Polymyxins / Q000008:administration & dosage* / Q000009:adverse effects*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D011113:Polymyxins; D006854:Hydrocortisone